AGIJ More info on CinGX
CinGx safe and effective
AGIJ More info on CinGX
CinGx safe and effective for treating diabetes, Alzheimer’s and dementia
inShare
There is currently no cure for Diabetes, Alzheimer's and Dementia but they can be treated and prevented. Allegiance Equity developed CinGx™ as a safe and effective treatment for these diseases. The incidence of these diseases and associated costs continue to soar out of control and afflict the world-wide population. Current treatments are not satisfactory and many have side effects.
CinGx™ controls glucose metabolism improves brain function and a healthy cognitive system. It contains two purified and concentrated natural extracts that act synergistically to control glucose metabolism, improve brain function, and minimize the risk of developing dementia, Alzheimer's and diabetes.
CinGx™ is effective against recently discovered 'type 3' diabetes resulting from lower than normal levels of newly detected brain insulin, causing Alzheimer's disease. Diabetes increases the risk of Alzheimer's disease by up to 65%.
CinGx™ is a natural proprietary OTC food additive and meets regulatory requirements in North America.
CinGx ™ AN EVOLUTION ON FUNCTIONAL FOODS
CinGx ™ provides exciting new Health Benefits in a multitude of food products resulting in distinct competitive advantages of
Increase demand
Higher Prices
Increased Margins and Profits
Applications include beverages, coffee, tea, sweeteners, diet foods, meal replacement, yogurt vitamins and diabetic products etc.
Demand for functional foods with proven Health Benefits is the fastest growing sector of the food industry.
Several manufacturers have developed new products containing CinGx™ to market.
Patent Approvals CinGx™
International Patent Applications have been issued and published for CinGx™ recognizing the health claims for TYPE 3 DIABETES.
SOURCE Allegiance Equity Corporation
Scroll down for more posts ▼
Top 10 Most Recent News Articles
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....
Continue Reading
You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...
Continue Reading
Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...
Continue Reading
A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...
Continue Reading
Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...
Continue Reading
What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...
Continue Reading
Top 5 Most Recently Viewed Articles
Sweden’s Finance Ministry Adjusts Economic Growth Forecasts Sweden’s Finance Ministry has recently updated its economic growth projections, indicating a more cautious outlook through 2026. This revision reflects ongoing challenges within Sweden's economy, which is the largest in the Nordic region, compounded by increasing global uncertainties. Current Economic Growth...
Continue Reading
Photocure ASA (OSE: PHO), known as the Bladder Cancer Company, rolled out a Named Patient Program (NPP) in 2024 aimed at providing access to their innovative product, Hexvix. This move followed their partnership with Equity Pharmaceuticals from the Clinigen Group, intending to get Hexvix into the hands of physicians for specific patients dealing with suspected or...
Continue Reading
Wall Street's Dynamic Momentum As Wall Street enters a new trading week, excitement pulses through the markets. The Dow has reached unprecedented heights, and the S&P 500 is nearing its own record. Meanwhile, the Nasdaq is riding a wave of enthusiasm driven by Nvidia’s anticipated performance. Trader sentiment is high, but critical factors loom ahead that could shift...
Continue Reading
OptimizeRx Expands Partnership with Leading Pharma Client OptimizeRx Corp (Nasdaq: OPRX), a leader in healthcare technology solutions, has made a significant advancement by broadening its strategic partnership with a major pharmaceutical client. This collaboration now includes a remarkable commitment of over $10 million, underscoring the company's dedication to innovation...
Continue Reading
Introducing the SKAURA ONE™ Razor SKAURA has unveiled its latest creation: the SKAURA ONE™, a patented razor that reimagines the grooming experience with its innovative design. This razor is not just a tool; it embodies a philosophy centered around clinical precision, balance, and thoughtfulness in every shave. Designed through extensive research and crafted with a...
Continue Reading